What is pyroglutamic (5‑oxoproline) acidosis, its risk factors, and the recommended management?

Pyroglutamic Acidosis (5-Oxoproline Acidosis)

Pyroglutamic acidosis is an underrecognized cause of high anion gap metabolic acidosis that occurs when glutathione depletion leads to accumulation of pyroglutamic acid (5-oxoproline), most commonly triggered by chronic acetaminophen use in patients with additional risk factors for glutathione deficiency.

What It Is

Pyroglutamic acid is an endogenous organic acid and intermediate metabolite in the γ-glutamyl cycle involved in glutathione metabolism 1. When glutathione stores become depleted, pyroglutamic acid accumulates and causes high anion gap metabolic acidosis 2. This can occur through:

• Inherited forms: Rare autosomal recessive defects in glutathione synthetase, typically diagnosed in children 1
• Acquired forms: Much more common in adults, associated with medications and clinical conditions that deplete glutathione 3

Risk Factors

The classic patient is a chronically ill, malnourished woman with multiple glutathione-depleting conditions 4. Specific risk factors include:

Medication-Related

• Chronic acetaminophen use (even at therapeutic doses) 2, 3, 5
• Valproate, vigabatrin, and other antiepileptic drugs 1

Clinical Conditions

• Malnutrition 4, 5
• Sepsis and critical illness 2, 6
• Renal impairment 4, 5
• Chronic liver disease 3
• Pregnancy 3, 5
• Alcohol abuse 3
• Advanced age 3
• Female gender 3

Important caveat: Septic shock patients with acidosis may have elevated pyroglutamic acid levels even without acetaminophen exposure 6. In one prospective study, 50% of patients with high pyroglutamic acid levels had septic shock, suggesting this condition plays a role in critically ill populations 6.

Diagnosis

Consider pyroglutamic acidosis in any patient with unexplained high anion gap metabolic acidosis who has risk factors, particularly when common causes (lactate, ketones, renal failure, toxins) have been excluded 5, 7.

Diagnostic Approach

• Calculate the anion gap in patients with metabolic acidosis 5
• Exclude common causes: lactic acidosis, ketoacidosis, renal failure, toxic ingestions (salicylate, methanol, ethylene glycol) 7
• Obtain urine organic acid analysis - this is the definitive test 1
  • Urine levels ≥63 µmol/mmol creatinine are considered elevated 6
  • Collect urine during acute illness when metabolites are highest 1
  • Store frozen until analyzed 1

Clinical clue: Patients with pyroglutamic acidosis may have lower blood pH and paradoxically lower serum lactate compared to other causes of high anion gap acidosis 6.

Management

Immediately discontinue acetaminophen and provide supportive care; consider N-acetylcysteine for persistent acidosis 3, 4.

Treatment Algorithm

1. Stop acetaminophen immediately 3, 5

   • This is the single most important intervention
   • The condition is entirely reversible once causative agents are withdrawn 5

2. Provide supportive care 3

   • Address metabolic acidosis with standard supportive measures
   • Correct volume status and electrolyte abnormalities

3. Address underlying glutathione deficiency 3

   • Improve nutritional status
   • Treat sepsis/infection
   • Optimize renal function

4. Consider N-acetylcysteine administration 4

   • This is particularly important if acidosis persists despite stopping acetaminophen
   • N-acetylcysteine replenishes glutathione and cysteine stores
   • One case report demonstrated rapid resolution of acidosis with N-acetylcysteine when discontinuation of acetaminophen alone was insufficient 4

Prognosis

The prognosis is excellent with prompt recognition and appropriate management 5. The condition is entirely reversible, but inappropriate management can contribute to patient morbidity and mortality 2. Recurrence can occur if acetaminophen is reintroduced in patients with persistent risk factors 3.

Common Pitfalls

• Underdiagnosis: This condition is likely significantly underdiagnosed given the prevalence of risk factors in hospitalized populations 5
• Mixed acid-base disorders: A more nuanced acid-base analysis may be required when multiple acid-base disturbances coexist 5
• Assuming therapeutic acetaminophen is safe: Even therapeutic doses can cause pyroglutamic acidosis in susceptible patients 3, 5
• Missing the diagnosis in septic patients: Consider pyroglutamic acidosis even without acetaminophen exposure in critically ill patients with septic shock 6